People use antibiotics far too often, with the result that pathogenic bacteria are becoming more and more resistant to these drugs. However, there is also another cause of increasing resistance, which has now been uncovered by Würzburg scientists who research infectious diseases.
Many infections that used to mean certain death can nowadays usually be overcome quickly by taking a few tablets. This is all thanks to antibiotics. So, it is all the more disturbing to physicians and patients alike that many pathogenic bacteria are becoming increasingly resistant to antibiotics.
From a colony of Staphylococcus aureus bacteria (middle, orange), groups that produce an antibiotic (white) and groups that are resistant to this antibiotic (periphery, yellow) gradually develop.
(Photo: Daniel Lopez)
This is particularly problematic in hospitals when bacteria spread that have become resistant to several antibiotics at the same time: these pathogens can be life-threatening for older and vulnerable patients. Sometimes such bacteria can be found in so-called biofilms on medical instruments or implants: they settle there in relatively large colonies inside a shared protective shell, which makes them even less receptive to drugs.
How is it that bacteria are becoming increasingly resistant? “It is because they come into contact with antibiotics too often and develop defense mechanisms,” according to the scientifically accepted explanation. Resistance is partly encouraged by the fact that physicians prescribe antibiotics too frequently and often even without good reason and by the fact that the agents are often mixed with food prophylactically in factory farming.
Competition between bacteria leads to resistance
Würzburg researchers have now discovered another way in which bacteria can become resistant – and surprisingly it has nothing to do with antibiotics used by humans. “Resistance already arises when competing bacteria live together in large numbers and in confined spaces,” says Dr. Daniel Lopez from the Research Center for Infectious Diseases at the University of Würzburg.
The scientists discovered this during experiments with Staphylococcus aureus bacteria, which are not resistant to antibiotics. They kept the bacteria under the conditions that prevail in a biofilm, i.e. numerous individuals in a confined space with a limited supply of nutrients.
A small evolution takes place in the biofilm
In this environment the Staphylococci become rivals and experience a kind of small-scale evolution: individual bacteria that are suddenly able to produce antibiotics through spontaneous mutations have the advantage. They keep the competition at a distance and multiply successfully. It is normal for bacteria to produce antibiotics themselves: even “in the wild” they use these agents to assert themselves against other bacteria, and many commonly prescribed antibiotics are derived from bacterial antibiotics.
In the biofilm created by the Würzburg researchers, the initial bacteria did not meekly surrender to this attack: they in turn developed mechanisms to defend themselves against the antibiotics, rendering themselves resistant. After just five days, there were three very distinctive groups of bacteria in the biofilm: the “harmless” original bacteria, the antibiotics producers, and the antibiotic-resistant group. This is reported by the Würzburg researchers in the current issue of the journal “Cell”.
Biofilms as breeding grounds for resistance
“Biofilms can therefore be breeding grounds for resistance without coming into contact with antibiotics from outside,” says Daniel Lopez. Consequently, hospitals should take even more care than they already do to prevent and combat biofilms. As their next step, the Würzburg researchers want to find out further details about what happens in biofilms. They are particularly interested in whether and how the ominous resistance development processes can be prevented.
“Evolution of Resistance to a Last-Resort Antibiotic in Staphylococcus aureus via Bacterial Competition”, Gudrun Koch, Ana Yepes, Konrad U. Förstner, Charlotte Wermser, Stephanie T. Stengel, Jennifer Modamio, Knut Ohlsen, Kevin R. Foster, and Daniel Lopez, Cell, Vol. 158, Issue 5, p1060–1071, 28. August 2014, DOI: 10.1016/j.cell.2014.06.046
Dr. Daniel Lopez, leader of the junior research group “Bacterial Cell Differentiation”, Research Center for Infectious Diseases, University of Würzburg, T +49 (0)931 31-83831, firstname.lastname@example.org
Daniel Lopez’s homepage: http://www.imib-wuerzburg.de/research/lopez/group-leader
Robert Emmerich | idw - Informationsdienst Wissenschaft
Microbe hunters discover long-sought-after iron-munching microbe
24.10.2016 | Max-Planck-Institut für marine Mikrobiologie
Seeking balanced networks: how neurons adjust their proteins during homeostatic scaling.
24.10.2016 | Max-Planck-Institut für Hirnforschung
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Life Sciences
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology